CME Sues US Regulator to Block Kalshi's 'Perp' Futures

CME Group has filed a lawsuit against a US regulatory agency in an effort to prevent rival platform Kalshi from offering popular 'perpetual' (perp) futures products. The legal action comes amid intensifying competition in the derivatives markets. The lawsuit alleges that Kalshi's perpetual futures contracts directly compete with CME's existing products and violate the regulatory framework. CME argues that such products create an unfair advantage in the market. Kalshi has drawn attention with its perpetual futures, which are particularly popular among retail investors. The platform offers users more flexible and accessible derivative products, positioning itself as an alternative to traditional exchanges. Experts note that the outcome of this case could have significant implications for future regulations of US derivatives markets. CME's legal initiative may reshape competitive dynamics in the sector. This is not investment advice.